Urinary immunocytology for primary bladder B cell lymphoma.
D000368:Aged; D018951:Antigens, CD20 / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000737:chemistry*; D015415:Biomarkers; D002699:Chlorambucil / Q000008:administration & dosage; D003131:Combined Modality Therapy; D015653:Cystectomy; D003556:Cystitis / Q000175:diagnosis; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000737:chemistry; D008197:Lymph Node Excision; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000652:urine*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000652:urine*; D008942:Mitoxantrone / Q000008:administration & dosage; D014411:Neoplastic Stem Cells / Q000737:chemistry*; D011239:Prednisolone / Q000008:administration & dosage; D011776:Pyuria / Q000175:diagnosis; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000652:urine*; D014556:Urine / Q000166:cytology*
D018951:Antigens, CD20; D000951:Antigens, Neoplasm; D015415:Biomarkers; D002699:Chlorambucil; D011239:Prednisolone; D008942:Mitoxantrone